Baudax Bio (BXRX) Institutional Ownership → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free BXRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Baudax Bio (NASDAQ:BXRX)CurrentInstitutional OwnershipPercentage9.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$52.65KNumber ofInstitutional Sellers(last 12 months)0 Get BXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Baudax Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BXRX Institutional Buying and Selling by Quarter Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. Baudax Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/21/2023Creative Planning45,001$53K0.0%N/A0.657% 11/7/2022Virtu Financial LLC108,332$27K0.0%+428.3%0.542% 11/7/2022 Warberg Asset Management LLC270,000$66K0.0%+682.6%1.350% 8/8/2022Walleye Capital LLC195,095$165K0.0%N/A3.037% 5/13/2022 Warberg Asset Management LLC34,500$61K0.0%N/A0.537% 2/14/2022 GSA Capital Partners LLP694,276$152K0.0%N/A0.684% Get the Latest News and Ratings for BXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter. 1/28/2022 Amplius Wealth Advisors LLC248,375$54K0.0%N/A0.245% 11/9/2021BlackRock Inc.1,329,684$749K0.0%+1.5%1.575% 8/16/2021State Street Corp284,553$216K0.0%N/A0.337% 8/16/2021Goldman Sachs Group Inc.151,323$115K0.0%N/A0.179% 8/13/2021Geode Capital Management LLC534,792$406K0.0%+30.7%0.634% 8/13/2021Vanguard Group Inc.3,727,800$2.84M0.0%-4.1%4.417% 5/17/2021Edmond DE Rothschild Holding S.A.100,000$129K0.0%N/A0.143% 5/14/2021MML Investors Services LLC45,000$58K0.0%N/A0.064% 5/13/2021 Bank of New York Mellon Corp101,229$131K0.0%N/A0.144% 5/12/2021Northern Trust Corp170,876$220K0.0%+158.8%0.244% 5/12/2021Geode Capital Management LLC409,190$527K0.0%+460.4%0.583% 5/7/2021BlackRock Inc.1,445,238$1.87M0.0%+735.8%2.060% 2/24/2021Alyeska Investment Group L.P.80,870$82K0.0%N/A0.115% 2/16/2021Alyeska Investment Group L.P.80,870$82K0.0%N/A0.190% 2/16/2021Armistice Capital LLC3,503,351$3.54M0.1%N/A4.995% 2/16/2021Corsair Capital Management L.P.90,752$92K0.0%-79.0%0.213% 2/10/2021Renaissance Technologies LLC422,200$426K0.0%+1,096.0%0.990% 2/4/2021 GSA Capital Partners LLP221,287$223K0.0%N/A0.519% 11/16/2020Oberweis Asset Management Inc.133,160$369K0.1%-15.3%0.507% 11/12/2020Arrowstreet Capital Limited Partnership227,314$630K0.0%-13.9%1.237% 9/15/2020Schonfeld Strategic Advisors LLC10,200$42K0.0%N/A0.056% 8/17/2020Jane Street Group LLC39,636$164K0.0%N/A0.216% 8/14/2020Man Group plc12,490$52K0.0%N/A0.068% 8/14/2020Verition Fund Management LLC27,000$112K0.0%N/A0.147% 8/14/2020Ikarian Capital LLC100,000$415K0.0%N/A0.544% 8/14/2020Advisor Group Holdings Inc.10,123$41K0.0%N/A0.055% 8/13/2020Johnson Investment Counsel Inc.10,000$42K0.0%N/A0.057% 8/12/2020Goldman Sachs Group Inc.10,094$42K0.0%N/A0.057% 8/12/2020 Bank of New York Mellon Corp11,861$49K0.0%N/A0.068% 8/12/2020Commonwealth Equity Services LLC163,364$677K0.0%N/A0.930% 8/12/2020 California Public Employees Retirement System27,200$113K0.0%N/A0.155% 8/3/2020Leap Investments LP19,000$79K0.1%N/A0.108% 7/31/2020UBS Group AG5,929$25K0.0%N/A0.034% 7/23/2020Creative Planning25,000$104K0.0%N/A0.142% The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide6/19/2020State Street Corp169,815$421K0.0%N/A0.967% (Data available from 1/1/2016 forward) BXRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BXRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Baudax Bio shares: Walleye Capital LLC ($165K), Warberg Asset Management LLC ($66K), and Creative Planning ($53K), Virtu Financial LLC ($27K).Learn more on BXRX's institutional investors. What percentage of Baudax Bio stock is owned by institutional investors? 9.05% of Baudax Bio stock is owned by institutional investors. Learn more on BXRX's institutional investor holdings. Which institutional investors have been buying Baudax Bio stock? The following institutional investors have purchased Baudax Bio stock in the last 24 months: Warberg Asset Management LLC ($270K), Walleye Capital LLC ($195.10K), Virtu Financial LLC ($87.83K), and Creative Planning ($45.00K). How much institutional buying is happening at Baudax Bio? Institutional investors have bought a total of 597,924 shares in the last 24 months. This purchase volume represents approximately $7.75M in transactions. Related Companies: EVLO Major Shareholders SBFM Major Shareholders LSDI Major Shareholders PBLA Major Shareholders NBSE Major Shareholders BLPH Major Shareholders INM Major Shareholders ADTX Major Shareholders GLMD Major Shareholders ATNF Major Shareholders This page (NASDAQ:BXRX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baudax Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.